Hydroxycitric acidCAS# 6205-14-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 6205-14-7 | SDF | Download SDF |
PubChem ID | 123908 | Appearance | Powder |
Formula | C6H8O8 | M.Wt | 208.12 |
Type of Compound | Miscellaneous | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1,2-dihydroxypropane-1,2,3-tricarboxylic acid | ||
SMILES | C(C(=O)O)C(C(C(=O)O)O)(C(=O)O)O | ||
Standard InChIKey | ZMJBYMUCKBYSCP-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C6H8O8/c7-2(8)1-6(14,5(12)13)3(9)4(10)11/h3,9,14H,1H2,(H,7,8)(H,10,11)(H,12,13) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. (-)-Hydroxycitric acid (HCA) can inhibit fat synthesis and reduces food intake, the primary mechanism of action of HCA appears to be related to its ability to act as a competitive inhibitor of the enzyme ATP-citrate lyase, which catalyzes the conversion of citrate and coenzyme A to oxaloacetate and acetyl coenzyme A (acetyl-CoA), primary building blocks of fatty acid and cholesterol synthesis. 2. Hydroxycitric acid ameliorates high-fructose-induced redox imbalance and activation of stress sensitive kinases in male Wistar rats through its hypolipidemic effects. |
Targets | Fatty Acid Synthase | ERK | p38MAPK |
Hydroxycitric acid Dilution Calculator
Hydroxycitric acid Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.8049 mL | 24.0246 mL | 48.0492 mL | 96.0984 mL | 120.123 mL |
5 mM | 0.961 mL | 4.8049 mL | 9.6098 mL | 19.2197 mL | 24.0246 mL |
10 mM | 0.4805 mL | 2.4025 mL | 4.8049 mL | 9.6098 mL | 12.0123 mL |
50 mM | 0.0961 mL | 0.4805 mL | 0.961 mL | 1.922 mL | 2.4025 mL |
100 mM | 0.048 mL | 0.2402 mL | 0.4805 mL | 0.961 mL | 1.2012 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Onitisin 2'-O-glucoside
Catalog No.:BCN4150
CAS No.:62043-53-2
- 4-(Dimethylamino)cinnamaldehyde
Catalog No.:BCN4968
CAS No.:6203-18-5
- Ginsenoside F3
Catalog No.:BCN1077
CAS No.:62025-50-7
- Ginsenoside F2
Catalog No.:BCN1245
CAS No.:62025-49-4
- Juncusol
Catalog No.:BCN2926
CAS No.:62023-90-9
- Cyclobenzaprine HCl
Catalog No.:BCC6496
CAS No.:6202-23-9
- Bulgarsenine
Catalog No.:BCN2065
CAS No.:62018-77-3
- Helichrysetin
Catalog No.:BCN4149
CAS No.:62014-87-3
- p-Menthane-1,2,8-triol
Catalog No.:BCN4148
CAS No.:62014-81-7
- Dirithromycin
Catalog No.:BCC4656
CAS No.:62013-04-1
- CCG-63808
Catalog No.:BCC1461
CAS No.:620113-73-7
- CCG-63802
Catalog No.:BCC1460
CAS No.:620112-78-9
- Nudiposide
Catalog No.:BCN7437
CAS No.:62058-46-2
- Heliotrine N-oxide
Catalog No.:BCN1983
CAS No.:6209-65-0
- 3-Nitro-L-tyrosine
Catalog No.:BCN2213
CAS No.:621-44-3
- Isovanillin
Catalog No.:BCN2502
CAS No.:621-59-0
- Scutebarbatine E
Catalog No.:BCN8396
CAS No.:910099-77-3
- Benzyl carbamate
Catalog No.:BCC8871
CAS No.:621-84-1
- Rauwolscine hydrochloride
Catalog No.:BCC6834
CAS No.:6211-32-1
- Boc-Phe(4-Br)-OH
Catalog No.:BCC3159
CAS No.:62129-39-9
- Boc-Phe(4-I)-OH
Catalog No.:BCC3260
CAS No.:62129-44-6
- N-Methylcyclohexaneethaneamine
Catalog No.:BCN1795
CAS No.:62141-38-2
- Z-Prolinol
Catalog No.:BCC2709
CAS No.:6216-63-3
- (-)-Syringaresinol
Catalog No.:BCN3417
CAS No.:6216-81-5
Hydroxycitric acid ameliorates high-fructose-induced redox imbalance and activation of stress sensitive kinases in male Wistar rats.[Pubmed:26974136]
J Basic Clin Physiol Pharmacol. 2016 Jun 1;27(4):349-56.
BACKGROUND: Excess fructose consumption causes dyslipidemia, oxidative stress, and various complications. Hydroxycitric acid (HCA), one of the principal components of the fruit Garcinia cambogia, has been shown to possess antiobesity properties. The objective was to investigate the effects of HCA on redox imbalance and activation of stress sensitive kinases in high fructose-fed rats. METHODS: Male Wistar rats (n=40) were randomly divided into four groups with 10 rats in each group. The rats were fed with either standard rodent diet or 60% fructose diet and administered with HCA at a dose of 400 mg/kg body wt/day for 10 weeks. Body weight was measured once a week, and food intake was noted daily. At the end of the study, lipid profile and oxidative stress parameters were estimated. Expressions of stress sensitive kinases were analyzed in liver homogenates. RESULTS: Fructose-fed rats displayed elevated body weight, higher levels of plasma total cholesterol (TC), triacylglycerol (TAG), non-high-density lipoprotein cholesterol (non HDL-C), malondialdehyde (MDA), total oxidant status (TOS), oxidative stress index (OSI), lower levels of HDL-C, glutathione (GSH), glutathione peroxidase (GPx), and total antioxidant status (TAS). Fructose feeding caused higher phosphorylation of stress sensitive kinases ERK (1/2) and p38. Administration with HCA lowered body weight, food intake, TAG, non-HDL-C, MDA, TOS, and OSI and elevated GSH, GPx, and TAS levels. Reduced phosphorylation of ERK (1/2) and p38 mitogen-activated protein kinase (MAPK) was observed upon HCA treatment. CONCLUSIONS: Thus, HCA improved fructose induced redox imbalance and activation of stress sensitive kinases through its hypolipidemic effects.
Safety assessment of (-)-hydroxycitric acid and Super CitriMax, a novel calcium/potassium salt.[Pubmed:15234082]
Food Chem Toxicol. 2004 Sep;42(9):1513-29.
(-)-Hydroxycitric acid (HCA) is a principle constituent (10-30%) of the dried fruit rind of Garcinia cambogia, a plant native to Southeastern Asia. The dried rind has been used for centuries throughout Southeast Asia as a food preservative, flavoring agent and carminative. Extensive experimental studies show that HCA inhibits fat synthesis and reduces food intake. The objective of this review is to systematically review the available safety/toxicity literature on HCA to determine its safety in-use. The primary mechanism of action of HCA appears to be related to its ability to act as a competitive inhibitor of the enzyme ATP-citrate lyase, which catalyzes the conversion of citrate and coenzyme A to oxaloacetate and acetyl coenzyme A (acetyl-CoA), primary building blocks of fatty acid and cholesterol synthesis. Super CitriMax, a novel calcium/potassium-HCA extract (HCA-SX), is considerably more soluble and bioavailable than calcium-based HCA ingredients. Acute oral toxicity studies in animals demonstrate that CitriMax (50% HCA as calcium salt) has a low acute oral toxicity. In a subchronic study in rats, the gavage administration of HCA-SX at doses up to 2500 mg/kg/day for a period of 90 days caused a significant decrease in body weight and reduction in feed consumption without any adverse effects. The structure, mechanism of action, long history of use of HCA and other toxicity studies indicate that HCA-SX is unlikely to cause reproductive or developmental effects. HCA-SX was not mutagenic in the presence or absence of metabolic activation in Ames genotoxicity assays in strains TA98 and TA102. HCA-SX-induced increases in number of revertants in other strains (TA100 and TA1535 in the absence of metabolic activation and in strain TA1537 in the presence of metabolic activation) but these were not considered as biologically indicative of a mutagenic effect. In several, placebo-controlled, double-blind trials employing up to 2800 mg/day HCA, no treatment-related adverse effects were reported. There is sufficient qualitative and quantitative scientific evidence, including animal and human data suggesting that intake of HCA at levels up to 2800 mg/day is safe for human consumption.